For submission of your manuscript, please visit the Submit Manuscript page or alternatively, you may send it as an email attachment to editor.jcti@sciconxjournals.com
Welcome to the Journal of Clinical and Translational Immunology (JCTI), an international, peer-reviewed, open-access journal dedicated to advancing the understanding of the immune system and its translation into clinical practice. Our mission is to provide a platform that bridges fundamental immunology research with innovative clinical applications, fostering discoveries that improve patient care and global health outcomes.
✦ Our Focus:
JCTI publishes high-quality original research, reviews, clinical studies, and perspectives that explore:
✦ Why Publish with JCTI?
✦ Our Commitment:
The Journal of Clinical and Translational Immunology is committed to maintaining the highest standards of scientific rigor, ethical publishing, and constructive peer review. We aim to be a trusted source for groundbreaking discoveries and transformative insights in the field of immunology.
✦ Fast Editorial Execution and Review Process (FEE-Review Process)
Authors who are willing to publish their articles under this mode can make a pre-payment of € 99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).
Manuscripts accepted for publication will be charged regular APC.
Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.
✦ Join Our Community:
We invite researchers, clinicians, and healthcare professionals to contribute to this growing body of knowledge by submitting manuscripts, serving as reviewers, or engaging as readers. Together, we can translate immunological discoveries into meaningful clinical outcomes.